An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

One study found that semaglutide helps to improve liver health in people with metabolic dysfunction-associated steatohepatitis, a serious form of fatty liver disease. The use of semaglutide ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... New Human 'Multi-Zonal' Liver Organoids Improve Injury Survival in Rodents Apr. 16 ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Share on Pinterest Semaglutide may be effective in treating a form of fatty liver disease, new research shows. Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that ...